Exosomes in the Chemoresistance of Glioma: Key Point in Chemoresistance
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70401 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Xu Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Cancer Hospital of Daflian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Exosomes, Glioma, Drug Resistance, Neoplasm, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gliomas are the most ordinary primary virulent brain tumours and commonly used clinical treatments include tumour resection, radiation therapy and chemotherapy. Although significant progress has been made in recent years in progression‐free survival (PFS) and overall survival (OS) for patients with high‐grade gliomas, the prognosis for patients remains poor. Chemoresistance refers to the phenomenon of decreased sensitivity of tumour cells to drugs, resulting in reduced or ineffective drug efficacy, and is an important cause of failure of tumour chemotherapy. Exosomes, a type of extracellular vesicle, are secreted by cancer cells and various stromal cells in the tumour microenvironment (TME) and transfer their inclusions to cancer cells, increasing chemoresistance. Furthermore, depletion of exosomes reverses certain detrimental effects on tumour metabolism and restores sensitivity to chemotherapeutic agents. Here, we summarised the correlation between exosomes and resistance to chemotherapeutic agents in glioma patients, the mechanisms of action of exosomes involved in resistance and their clinical value. We aimed to afford new thoughts for research, clinical diagnosis and intervention in the mechanisms of chemoresistance in glioma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Cancer Hospital of Daflian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.
ORCID-Profile: Xu Guo
Zitieren
APA
Guo, X., Piao, H., & Sui, R. (2025). Exosomes in the Chemoresistance of Glioma: Key Point in Chemoresistance. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70401
Vancouver
Guo X, Piao H, Sui R. Exosomes in the Chemoresistance of Glioma: Key Point in Chemoresistance. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70401
BibTeX
@article{Guo2025,
author = {Guo, Xu and Piao, Haozhe and Sui, Rui},
title = {Exosomes in the Chemoresistance of Glioma: Key Point in Chemoresistance},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70401}
}
EUVIMED